🔴 Alzamend Neuro is trading 10.43% down in after-hours trading as major indexes fell

Alzamend Neuro is trading 10.43% down at $1.46, aligned with broad risk-off sentiment after the August 20, 2026 regular session closed at $1.63.

• No negative company-specific announcement was identified; the latest company news was positive.
• AL001 neuroimaging data were accepted for a Neuroscience 2026 poster presentation.
• The S&P 500 fell 0.80%, the Nasdaq Composite dropped 1.11%, and the Dow declined 1.26%.